1.Date of the board of directors' resolution:2024/03/12
2.Shareholders meeting date:2024/06/25
3.Shareholders meeting location:Monarch Skyline Hotel B1 Purple Cloud Hall 2
(located at No.108, Sec 1, Nankan Rd, Luzhu Dist., Taoyuan City 338, Taiwan)
4.Shareholders' meeting will be held by means of (physical shareholders'
 meeting/ hybrid shareholders' meeting /
virtual-only shareholders' meeting):physical shareholders meeting
5.Cause for convening the meeting (1)Reported matters:
(1)2023 Business Report.
(2)Audit Committee's Review Report on 2023 financial results.
(3)2023 employees' and directors' remuneration distribution.
(4)2023 directors' remuneration Report.
6.Cause for convening the meeting (2)Acknowledged matters:
(1)2023 Business Report and Financial Statements.
(2)2023 earnings distribution.
7.Cause for convening the meeting (3)Matters for Discussion:
(1)To authorize the Board of Directors to handle matters related of the cash
capital increase of Formosa Pharmaceuticals Inc. within the next year.
(2)Proposed release the Directors and their representatives from
non-competition restrictions.
8.Cause for convening the meeting (4)Election matters:None
9.Cause for convening the meeting (5)Other Proposals:None
10.Cause for convening the meeting (6)Extemporary Motions:None
11.Book closure starting date:2024/04/27
12.Book closure ending date:2024/06/25
13.Any other matters that need to be specified:None